Financials
- Market Capitalization 4.49 M
- Employee 1
- Founded 2020
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4981 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 0.37 USD | +5.71% | +2.78% | +8.82% | -79.44% | 4.74 M USD | ||
| 4986 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.21 USD | +4.31% | +11.01% | -4.72% | -62.54% | 4.60 M USD | ||
| 4993 | FBLG FibroBiologics, Inc. - Common Stock | 0.85 USD | -1.16% | +3.66% | -2.30% | +23.19% | 4.43 M USD | ||
| 5002 | ENSC Ensysce Biosciences, Inc. - Common Stock | 0.29 USD | +3.57% | +3.57% | +7.41% | -24.18% | 4.26 M USD |